# Cancer Mission Innovation Action – HORIZON-MISS-2026-02-CANCER-05

**Funder:** European Commission
**Budget:** Around €7M
**Deadline:** 15 September 2026 (17:00 Brussels time)
**Consortium:** Required — minimum 3 entities from 3 EU member states
**Application:** Single stage
**Frequency:** One-off
**Official call:** https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/calls-for-proposals?callIdentifier=HORIZON-MISS-2026-02
**Last verified:** 18 June 2026

## Eligibility & scope

Horizon Europe Innovation Action under the EU Cancer Mission call HORIZON-MISS-2026-02. One indicative grant of approximately €7M. Full topic description available in the Work Programme. Consortia must include eligible entities from at least 3 EU member states or associated countries.

## Summary

The Cancer Mission Innovation Action, HORIZON-MISS-2026-02-CANCER-05 offers approximately €7 million in Horizon Europe funding for applied cancer research projects led by multi-country consortia. This one-off call funds innovation actions that translate cancer research into clinical or public-health impact, with a focus on cross-border collaboration. Applicants must form consortia of at least 3 entities across 3 EU member states or associated countries.

## Who should apply

- Applied cancer researchers and clinicians ready to lead or co-lead a consortium
- Research institutions, hospital networks, and industry partners in EU member states or associated countries
- Teams with established multi-country partnerships or strong capacity to build them quickly
- Projects with a clear pathway to clinical implementation or health-system adoption

## Key dates

- Deadline: 15 September 2026, 17:00 Brussels time
- Single-stage application and evaluation
- Project duration: typically 4-5 years in Horizon Europe Innovation Actions

## Tips for applicants

- Consortium composition is gate-keeping, validate early that partners are eligible and committed before drafting the proposal.
- Horizon Europe reviewers weight feasibility and risk mitigation heavily; avoid over-ambitious timelines across three+ countries.
- The innovation angle must be clear: detail the end-user (clinicians, patients, industry) and the adoption or dissemination plan, not just the science.

## Frequently asked questions

### How much does the Cancer Mission Innovation Action grant provide?

Approximately €7 million in total Horizon Europe funding for the single indicative grant in this call.

### Who can apply for the Cancer Mission Innovation Action?

Consortia of at least 3 eligible entities from 3 different EU member states or associated countries; institutions, hospitals, and industry partners are eligible.

### What is the deadline for the Cancer Mission Innovation Action?

15 September 2026 at 17:00 Brussels time.

### Is this a recurring call?

No, this is a one-off call; there is no announced successor round.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/european-commission-cancer-mission-innovation-action-horizon-miss-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.